NasdaqGS:COLLPharmaceuticals
Is Collegium's (COLL) Real-World Pain Data Shaping Its Competitive Edge in Chronic Care?
Collegium Pharmaceutical recently announced its participation at PAINWeek 2025 in Las Vegas, where it will present nine posters featuring real-world data on BELBUCA and XTAMPZA ER, focusing on treatment characteristics, safety profiles, and clinical outcomes for chronic low back pain patients.
This initiative highlights Collegium’s ongoing commitment to providing healthcare professionals with meaningful evidence to inform pain management decisions and address the evolving needs of patients...